Beyond the Rat Models of Human Neurodegenerative Disorders

The rat is a model of choice in biomedical research for over a century. Currently, the rat presents the best “functionally” characterized mammalian model system. Despite this fact, the transgenic rats have lagged behind the transgenic mice as an experimental model of human neurodegenerative disorders. The number of transgenic rat models recapitulating key pathological hallmarks of Alzheimer’s disease, Huntington’s disease, amyotrophic lateral sclerosis, or human tauopathies is still limited. The reason is that the transgenic rats remain more difficult to produce than transgenic mice. The gene targeting technology is not yet established in rats due to the lack of truly totipotent embryonic stem cells and cloning technology. This extremely powerful technique has given the mouse a clear advantage over the rat in generation of new transgenic models. Despite these limitations, transgenic rats have greatly expanded the range of potential experimental approaches. The large size of rats permits intrathecal administration of drugs, stem cell transplantation, serial sampling of the cerebrospinal fluid, microsurgical techniques, in vivo nerve recordings, and neuroimaging procedures. Moreover, the rat is routinely employed to demonstrate therapeutic efficacy and to assess toxicity of novel therapeutic compounds in drug development. Here we suggest that the rat constitutes a slightly underestimated but perspective animal model well-suited for understanding the mechanisms and pathways underlying the human neurodegenerative disorders.

[1]  K. Kawakami,et al.  DNA transposons in vertebrate functional genomics , 2005, Cellular and Molecular Life Sciences.

[2]  A. Levey,et al.  Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically , 2008, BMC Neuroscience.

[3]  Y. Kuroiwa,et al.  Transgenic animal production and animal biotechnology. , 2007, Theriogenology.

[4]  R. Kaneko,et al.  Production of transgenic rats by ooplasmic injection of spermatogenic cells exposed to exogenous DNA: A preliminary study , 2004, Molecular reproduction and development.

[5]  Ronald Wetzel,et al.  Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. , 2006, Human molecular genetics.

[6]  K Lindpaintner,et al.  Why map the rat? , 1997, Trends in genetics : TIG.

[7]  Y. Itoyama,et al.  Disease progression of human SOD1 (G93A) transgenic ALS model rats , 2006, Journal of neuroscience research.

[8]  R. Wall.  New gene transfer methods. , 2002, Theriogenology.

[9]  Roland Brandt,et al.  O-Glycosylation of the Tail Domain of Neurofilament Protein M in Human Neurons and in Spinal Cord Tissue of a Rat Model of Amyotrophic Lateral Sclerosis (ALS)* , 2005, Journal of Biological Chemistry.

[10]  Olaf Riess,et al.  Cellular and subcellular localization of Huntington aggregates in the brain of a rat transgenic for Huntington disease , 2007 .

[11]  Houdebine Lm.  Use of Transgenic Animals to Improve Human Health and Animal Production , 2005 .

[12]  Andreas Bauer,et al.  Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation , 2005, Journal of neurochemistry.

[13]  M. Ueda,et al.  Generation of transgenic rats with YACs and BACs: preparation procedures and integrity of microinjected DNA. , 2000, Experimental animals.

[14]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein? (tau) in Alzheimer cytoskeletal pathology , 1987 .

[15]  K. Kosik,et al.  Phosphorylated tau and the neurodegenerative foldopathies. , 2005, Biochimica et biophysica acta.

[16]  Y. Itoyama,et al.  Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models , 2005, Acta Neuropathologica.

[17]  M. Szyf,et al.  Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex. , 2004, Journal of Alzheimer's disease : JAD.

[18]  R. Wall.  Sperm‐mediated gene transfer: advances in sperm cell research and applications , 1999, Transgenic research.

[19]  C. Milstein,et al.  Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Kabat,et al.  Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. , 1993, The EMBO journal.

[21]  Nathan R. Qi,et al.  Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension , 2008, Nature Genetics.

[22]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[23]  J. Rothstein,et al.  Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS , 2006, Neurobiology of Disease.

[24]  C. Spadafora,et al.  Sperm-mediated gene transfer: applications and implications. , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[25]  N. Zilka,et al.  Chaperone-like antibodies targeting misfolded tau protein: new vistas in the immunotherapy of neurodegenerative foldopathies. , 2008, Journal of Alzheimer's disease : JAD.

[26]  Thomas Walther,et al.  Transgenic rat model of Huntington's disease. , 2003, Human molecular genetics.

[27]  H. Reichardt,et al.  Lentivirally generated eGFP‐transgenic rats allow efficient cell tracking in vivo , 2004, Genesis.

[28]  G. Wenk,et al.  Animal Models of Alzheimer’s Disease , 1992 .

[29]  K. Kosik,et al.  Attenuated Hippocampus-Dependent Learning and Memory Decline in Transgenic TgAPPswe Fischer-344 Rats , 2004, Molecular medicine.

[30]  H. Jacob,et al.  Efficient transgenic rat production by a lentiviral vector , 2006, American journal of physiology. Heart and circulatory physiology.

[31]  Wanda Ogonowska,et al.  Progression of morphological changes within CNS in a transgenic rat model of familial amyotrophic lateral sclerosis. , 2006, Folia neuropathologica.

[32]  F. Canzian,et al.  Phylogenetics of the laboratory rat Rattus norvegicus. , 1997, Genome research.

[33]  C. Bishop,et al.  Generation of rat mutants using a coat color-tagged Sleeping Beauty transposon system , 2007, Mammalian Genome.

[34]  Jean-Marie Maloteaux,et al.  Loss of metabotropic glutamate receptor‐mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis , 2006, Journal of neurochemistry.

[35]  N. Nakatsuji,et al.  Production of Transgenic Rats via Lentiviral Transduction and Xenogeneic Transplantation of Spermatogonial Stem Cells1 , 2008, Biology of reproduction.

[36]  D. Frayer.  SEXUAL DIMORPHISM , 2005 .

[37]  K. Thiam,et al.  Use of genetically modified rat models for translational medicine. , 2008, Drug discovery today.

[38]  C. T. Dann.  New technology for an old favorite: lentiviral transgenesis and RNAi in rats , 2007, Transgenic Research.

[39]  H. Steinbusch,et al.  Motor and cognitive improvement by deep brain stimulation in a transgenic rat model of Huntington's disease , 2006, Neuroscience Letters.

[40]  A. Pfeifer.  Lentiviral transgenesis , 2004, Transgenic Research.

[41]  G. J. Smith,et al.  The rat as an experimental animal. , 1989, Science.

[42]  Peter J. Schaap,et al.  Molecular characterization of the , 1997 .

[43]  H. Jacob,et al.  Functional genomics and rat models. , 1999, Genome research.

[44]  T. Kurtz,et al.  Genetic isolation of quantitative trait loci for blood pressure development and renal mass on chromosome 5 in the spontaneously hypertensive rat. , 2003, Physiological research.

[45]  N. Kasai,et al.  Offspring Derived From Intracytoplasmic Injection of Transgenic Rat sperm , 2002, Transgenic Research.

[46]  J. Priestley,et al.  Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosis , 2007, Journal of neurochemistry.

[47]  J. Götz,et al.  Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.

[48]  T. Kurtz,et al.  Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats , 2001, Nature Genetics.

[49]  S. Remy,et al.  Transgenic Modifications of the Rat Genome , 2005, Transgenic Research.

[50]  A. Kowalczyk,et al.  Maintenance of the rat transgenic model of familial amyotrophic lateral sclerosis expressing human SOD1G93A mutation. , 2006, Folia neuropathologica.

[51]  G. Schatten,et al.  Sperm-mediated gene transfer. , 2000, Current topics in developmental biology.

[52]  L. Houdebine.  Relations between animal transgenesis and reproduction. , 2005, Reproduction, nutrition, development.

[53]  R. Kaneko,et al.  Factors affecting production of transgenic rats by ICSI‐mediated DNA transfer: Effects of sonication and freeze‐thawing of spermatozoa, rat strains for sperm and oocyte donors, and different constructs of exogenous DNA , 2005, Molecular reproduction and development.

[54]  R. Hammer,et al.  Production of transgenic rats by lentiviral transduction of male germ-line stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Y. Itoyama,et al.  Mild ALS in Japan associated with novel SOD mutation , 1993, Nature Genetics.

[56]  D. Corbett,et al.  Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats , 2007, The European journal of neuroscience.

[57]  D. Ganten,et al.  Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene , 1990, Nature.

[58]  T. Möller,et al.  Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats , 2004, Neuroreport.

[59]  R. Tomanin,et al.  Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction. , 2004, Current gene therapy.

[60]  Lisa M. D'Souza,et al.  Genome sequence of the Brown Norway rat yields insights into mammalian evolution , 2004, Nature.

[61]  Lung-Ji Chang,et al.  Efficient generation of transgenic rats through the male germline using lentiviral transduction and transplantation of spermatogonial stem cells. , 2006, Journal of andrology.

[62]  D. Ganten,et al.  Efficiency of transgenic rat production is independent of transgene-construct and overnight embryo culture. , 2004, Theriogenology.

[63]  Andreas Bauer,et al.  Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. , 2008, Human molecular genetics.

[64]  M. Ueda,et al.  Rescue of infertile transgenic rat lines by intracytoplasmic injection of cryopreserved round spermatids , 2002, Molecular reproduction and development.

[65]  Yasin Temel,et al.  Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats , 2006, Neurobiology of Disease.

[66]  F. Pedersen,et al.  Shielding of sleeping beauty DNA transposon-delivered transgene cassettes by heterologous insulators in early embryonal cells. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[67]  T. Neumann-Haefelin,et al.  Magnetic resonance imaging in basilar artery occlusion. , 2002, Archives of Neurology.

[68]  M. Lindstrom,et al.  Sexual dimorphism in disease onset and progression of a rat model of ALS , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[69]  B. Hyman,et al.  Transgenic models of Alzheimer’s disease: Learning from animals , 2005, NeuroRX.

[70]  M. Bader,et al.  Strain Differences in Superovulatory Response, Embryo Development and Efficiency of Transgenic Rat Production , 2005, Transgenic Research.

[71]  N. Zilka,et al.  Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats , 2007, Brain Research.

[72]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[73]  A. Burns,et al.  Alzheimer's disease , 2002, The Lancet.

[74]  A. Hill,et al.  Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis , 2005, The Journal of Neuroscience.

[75]  R. Hammer,et al.  Heritable and stable gene knockdown in rats. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Evon M. O. Abu-Taieh,et al.  Comparative Study , 2020, Definitions.

[77]  J. Rothstein,et al.  Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[78]  N. Zilka,et al.  NeuroScale, the battery of behavioral tests with novel scoring system for phenotyping of transgenic rat model of tauopathy , 2009, Journal of Neuroscience Methods.

[79]  B. Winblad,et al.  A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation. , 2007, Biochemical and biophysical research communications.

[80]  Robert H. Brown,et al.  Rats Expressing Human Cytosolic Copper–Zinc Superoxide Dismutase Transgenes with Amyotrophic Lateral Sclerosis: Associated Mutations Develop Motor Neuron Disease , 2001, The Journal of Neuroscience.

[81]  J. Cha.  Finding diamonds in the rubble , 2007, Experimental Neurology.

[82]  M. Nishihara,et al.  Production of Transgenic Rats and Mice by the Testis-Mediated Gene Transfer , 1999 .

[83]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[84]  K. Talbot,et al.  Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS , 2008, Progress in Neurobiology.

[85]  Y. Itoyama,et al.  Development of a rat model of amyotrophic lateral sclerosis expressing a human SOD1 transgene , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.

[86]  M. Ueda,et al.  A comparative study on the integration of exogenous DNA into mouse, rat, rabbit, and pig genomes. , 2001, Experimental animals.

[87]  Yasin Temel,et al.  Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel , 2006, Behavioural Brain Research.

[88]  T. Saunders,et al.  Advances in transgenic rat production , 2006, Transgenic Research.

[89]  O. Riess,et al.  Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat , 2006, Brain Research Bulletin.

[90]  Jason R. Thonhoff,et al.  Identification of early disease progression in an ALS rat model , 2007, Neuroscience Letters.

[91]  W. Streit,et al.  Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene , 2007, Journal of Neuroinflammation.

[92]  P. Filipcik,et al.  Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load , 2008, The European journal of neuroscience.

[93]  A. Rego,et al.  Mechanisms of neurodegeneration in Huntington’s disease , 2008, European Journal of Neuroscience.

[94]  D. Flood,et al.  A transgenic rat model of Alzheimer's disease with extracellular Aβ deposition , 2009, Neurobiology of Aging.

[95]  H. Harris,et al.  The Rat , 1958, Nature.

[96]  H. Bağış,et al.  Production of transgenic mice from vitrified pronuclear‐stage embryos , 2002, Molecular reproduction and development.

[97]  Megumi Kato,et al.  Direct comparison between ICSI-mediated DNA transfer and pronuclear DNA microinjection for producing transgenic rats. , 2008, Experimental animals.

[98]  A. Delacourte,et al.  Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer’s disease , 2002, Neurology.

[99]  Edwin Cuppen,et al.  Progress and prospects in rat genetics: a community view , 2008, Nature Genetics.

[100]  P. Filipcik,et al.  Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo , 2006, FEBS letters.

[101]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[102]  M. Bader,et al.  Generation and characterization of a GFP transgenic rat line for embryological research , 2008, Transgenic Research.

[103]  James Scott,et al.  Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats , 1999, Nature Genetics.

[104]  J. Weiss,et al.  Intrathecal infusion of a Ca2+-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS , 2007, Experimental Neurology.

[105]  A. Gutiérrez-Adán,et al.  Efficient Generation of Transgenic Mice with Intact Yeast Artificial Chromosomes by Intracytoplasmic Sperm Injection1 , 2004, Biology of reproduction.

[106]  L. Houdebine,et al.  Use of Transgenic Animals to Improve Human Health and Animal Production , 2005, Reproduction in domestic animals = Zuchthygiene.

[107]  D. Ganten,et al.  Comparison between PMSG‐ and FSH‐induced superovulation for the generation of transgenic rats , 2002, Molecular reproduction and development.

[108]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[109]  Ottavio Arancio,et al.  A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment , 2008, Neurobiology of Disease.

[110]  J. Walker,et al.  Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.